Elon Musk plans to aid Covid-19 drugmaker

Local drugmaker CureVac AG is getting a notable assistant in its mission to create a Covid-19 vaccine: Tesla Inc. CEO Elon Musk. CureVac, which is based in Germany with a U.S. headquarters in Boston, is developing a preventative drug for the novel coronavirus that uses a small element of the virus called the messenger RNA to trick the human body into producing disease-fighting antibodies. It’s not alone in taking this approach to tackle Covid-19 — Cambridge-based Moderna (Nasdaq: MRNA) and German…